[Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors]
- PMID: 1532436
[Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors]
Abstract
Background: Lipoprotein (Lp) (a) is considered a risk factor for early coronary heart disease (CHD), and a discriminant cutoff of Lp(a) concentration has been suggested.
Methods: Serum Lp(a) concentrations have been determined by enzymoimmunoassay in 66 men with CHD and in 100 healthy control men. Serum cholesterol, serum triglycerides, high density lipoprotein (HDL)-cholesterol, and apoprotein (apo) A-I were also determined.
Results: Serum Lp(a) concentration was 21.7 +/- 16.9 mg/dl (mean +/- SD) in patients and 12.5 +/- 12.5 mg/dl in controls (p less than 0.001). Serum cholesterol was 5.63 +/- 1.22 mmol/l and 5.29 +/- 1.00 mmol/l (p less than 0.05) respectively; serum triglycerides were 1.99 +/- 1.23 mmol/l and 1.29 +/- 0.61 mmol/l (p less than 0.001) respectively; HDL-cholesterol was 0.97 +/- 0.27 mmol/l and 1.07 +/- 0.30 mmol/l (p less than 0.05) respectively; and apo A-I was 94 +/- 15 mg/dl and 144 +/- 41 mg/dl (p less than 0.001) respectively. Lp(a) concentrations were not correlated with other well-recognized cardiovascular risk lipidic factors, nor influenced by age either body mass index. Using 20 mg/dl as discriminant Lp(a) concentration between patients and controls, a ratio 2:1 in patients with respect to controls has been observed and exceeded some more when the threshold level was put on 30 mg/dl. A subset of normocholesterolemic and normotriglyceridemic patients (n = 17) and controls (n = 49) had serum Lp(a) concentration of 22.7 +/- 16.3 mg/dl and 9.1 +/- 8.2 mg/dl (p less than 0.001) respectively.
Conclusions: Increased concentration of Lp(a) constitutes an independent risk factor for CHD. On the other hand, Lp(a) concentrations of 20 mg/dl or 30 mg/dl as risk threshold levels are well-defined.
Similar articles
-
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.J Clin Invest. 1992 Mar;89(3):1040-6. doi: 10.1172/JCI115645. J Clin Invest. 1992. PMID: 1541665 Free PMC article.
-
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.Arch Intern Med. 1996 Jun 10;156(11):1181-8. Arch Intern Med. 1996. PMID: 8639012 Clinical Trial.
-
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.Metabolism. 2008 Jun;57(6):791-5. doi: 10.1016/j.metabol.2008.01.020. Metabolism. 2008. PMID: 18502261
-
[Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation].Orv Hetil. 1997 Aug 10;138(32):2005-8. Orv Hetil. 1997. PMID: 9297170 Review. Hungarian.
-
Lipoprotein(a): more interesting than ever after 50 years.Curr Opin Lipidol. 2012 Apr;23(2):133-40. doi: 10.1097/MOL.0b013e32835111d8. Curr Opin Lipidol. 2012. PMID: 22327610 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous